Use of analgesic potentiating compounds to potentiate the analgesic properties of an analgesic compound
AssigneeSchabar Research Associates LLC
InventorBernard P. SCHACHTEL
Life of this patent
Estimating the term…
Loading patent…
AssigneeSchabar Research Associates LLC
InventorBernard P. SCHACHTEL
Estimating the term…
Described herein are methods for effectively and accurately measuring a patient response upon administration of one or more drugs to the patient. The methods are more sensitive than current methodologies. Also described herein are compositions comprising an analgesic and a sufficient amount of an antihistamine to enhance the analgesic properties of the analgesic. With respect to these compositions, the methods described herein are useful for evaluating qualities of pain, definite improvement, and one or more bodily functions of a subject afflicted with pain. The compositions described herein are useful in improving the quality of pain in a subject or a bodily function of a subject afflicted with pain or definite improvement of a subject afflicted with pain.
A method for enhancing an analgesic response in a human desiring treatment for reducing acute pain which comprises orally administering to said human having acute pain a single dose composition comprising (i) an analgesic effective amount of a compound selected from the group consisting of naproxen and the pharmaceutically acceptable salt thereof at a dosage from 100 mg to 900 mg per single dose composition, and (ii) an analgesic potentiating amount of a compound selected from the group consisting of nizatidine and the pharmaceutically effective salt or isomer thereof at a dosage from 10 mg to 200 mg per single dose composition,
Dependencies are inferred from the claim text.